This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Drug Hunter Reviewer Commentary. With over two decades of experience in neuroscience drug discovery, Drug Hunter reviewer Jake Schwarz says…
molecule
6 months ago ●
7 mins read
We're here at ACS Chicago 2022, covering sections of particular interest to drug discovery scientists. Among the highlights are the…
Article
1 year ago ●
4 mins read
A KIT-selective, non-classical hinge binder-containing kinase inhibitor with best-in-class potential for the treatment of GIST. M4205 (IDRX-42) is a highly…
molecule
6 months ago ●
6 mins read
This article is Part 5 of a review series covering all the initial public offerings for the biotech and pharmaceutical…
Article
1 year ago ●
7 mins read
Overview. A common route of resistance to tuberculosis involves Mtb erm37 expression, which expresses an RNA methyltransferase that methylates the…
molecule
6 months ago ●
4 mins read
As biotech experts, risk taking is part of our business model. Without scientific and business risk, inventions would not occur…
Article
1 year ago ●
8 mins read
Load More
